The long term goal of the research proposed in this application is to understand the mechanisms that underlie the formation of functionally appropriate synaptic connections during development of the nervous system. An important aspect of this process is the determination of the neurotransmitter phenotype of individual neurons. Recently, neuroscientists have recognized that many neurons contain a neuropeptide(s) in addition to a classical neurotransmitter. Neuropeptides have been shown to function as neuro-transmitters or neuromodulators in the adult and some evidence suggests that they may play important roles in development as well. These findings raise the obvious questions of when neuropeptides appear during development and what factors influence the neuropeptide(s) a neuron will express. Preliminary data obtained in studies of rat sympathetic neurons developing in vivo suggest that some neuropeptides appear very early, that individual neurons transiently express multiple neuropeptides, and that experimental manipulation during development can alter peptide phenotype in a striking fashion. Further, we have evidence that peptide function in a class of neurons, parasympathetic ciliary neurons, can be controlled post-translationally. Using immunocytochemidstry and in situ hybridization, we will determine when neuropeptides and the mRNAs that encode them are first expressed in developing sympathetic cells and whether changes in expression occur. By interfering with normal neuron-target interactions, we will examine plasticity of neuropeptide expression and study how peptidergic phenotypes are established in vivo. Finally, we will study the development of processing of one neuropeptide, Neuropeptide Y, in sympathetic neurons and the possible role that processing, packaging and/or transport may play in regulating its function. This latter will be accomplished by using rat ciliary neurons, cells in which these functions can be altered experimentally. The studies proposed will provide important new information concerning the development of neuropeptide expression, processing and transport. They may elucidate the pathogenesis of developmental disorders of the nervous system and of neurodegenerative disease involving peptide dysfunction.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025681-02
Application #
3326875
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1989-04-01
Project End
1994-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Francis, N; Farinas, I; Brennan, C et al. (1999) NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol 210:411-27
Fagan, A M; Zhang, H; Landis, S et al. (1996) TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J Neurosci 16:6208-18
Landis, S C (1996) The development of cholinergic sympathetic neurons: a role for neuropoietic cytokines? Perspect Dev Neurobiol 4:53-63
Sun, Y; Landis, S C; Zigmond, R E (1996) Signals triggering the induction of leukemia inhibitory factor in sympathetic superior cervical ganglia and their nerve trunks after axonal injury. Mol Cell Neurosci 7:152-63
Tyrrell, S; Landis, S C (1994) The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression. J Neurosci 14:4529-47
Lewis, S E; Rao, M S; Symes, A J et al. (1994) Coordinate regulation of choline acetyltransferase, tyrosine hydroxylase, and neuropeptide mRNAs by ciliary neurotrophic factor and leukemia inhibitory factor in cultured sympathetic neurons. J Neurochem 63:429-38
Schotzinger, R; Yin, X; Landis, S (1994) Target determination of neurotransmitter phenotype in sympathetic neurons. J Neurobiol 25:620-39
Mohney, R P; Siegel, R E; Zigmond, R E (1994) Galanin and vasoactive intestinal peptide messenger RNAs increase following axotomy of adult sympathetic neurons. J Neurobiol 25:108-18
Tyrrell, S; Landis, S C (1994) Disruption of target interactions prevents the development of enkephalin immunoreactivity in sympathetic neurons. J Neurosci 14:5708-21
Sun, Y; Rao, M S; Zigmond, R E et al. (1994) Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor. J Neurobiol 25:415-30

Showing the most recent 10 out of 18 publications